Pieris Pharmaceuticals, Inc (PIRS) CEO Stephen S. Yoder on Q1 2022 Results - Earnings Call Transcript
Pieris Pharmaceuticals, Inc (NASDAQ:NASDAQ:PIRS) Q1 2022 Earnings Conference Call May 11, 2022, 8:00 AM ET Company Participants Stephen S.
Source: seekingalpha.com